Craft

Cencora

Stock Price

$231.8

2024-10-29

Market Capitalization

$45.4 B

2024-10-29

Revenue

$321.3 B

FY, 2025

Cencora Summary

Company Summary

Overview
Cencora (formerly known as AmerisourceBergen) is a company that sources and distributes pharmaceutical products. It offers vaccines, parasiticides, home healthcare supplies and equipment, blood components, etc. The company also provides drug research and clinical development, logistics, warehousing, commercialization support, and other services. Cencora caters to the healthcare, pharmacies, transportation, and logistics sectors.
Type
Public
Status
Active
Founded
2001
HQ
Conshohocken, PA, US | view all locations
Website
https://www.cencora.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Robert P. Mauch

    Robert P. Mauch, President and Chief Executive Officer

  • Steven H. Collis
  • Elizabeth Campbell

    Elizabeth Campbell, Executive Vice President and Chief Legal Officer

  • James F. Cleary

    James F. Cleary, Executive Vice President and Chief Financial Officer

Operating MetricsView all

Countries

50

FY, 2022

Average Daily Deliveries (Wholesale Distribution Centers)

25K

FY, 2020

Products Shipped Daily

6.7B
48.9%

FY, 2022

LocationsView all

4 locations detected

  • Conshohocken, PA HQ

    United States

    1 West First Avenue

  • Buford, GA

    United States

    3930 Mason Mill Rd

  • SeaTac, WA

    United States

    2141 S 211th St a

  • Bern, BE

    Switzerland

    Bogenschützenstrasse 9B

Cencora Financials

Summary Financials

Revenue (Q2, 2026)
$78.4B
Gross profit (Q2, 2026)
$3.6B
Net income (Q2, 2026)
$1.6B
Cash (Q2, 2026)
$2.2B
EBIT (Q2, 2026)
$1.1B
Enterprise value
$55.6B

Footer menu